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Abstract. We conducted a survey involving 1,604 households to determine community care-seeking patterns and
163 exit interviews to determine appropriateness of treatment of common childhood illnesses at private sector drug shops
in two rural districts of Uganda. Of children sick within the last 2 weeks, 496 (53.1%) children first sought treatment in
the private sector versus 154 (16.5%) children first sought treatment in a government health facility. Only 15 (10.3%)
febrile children treated at drug shops received appropriate treatment for malaria. Five (15.6%) children with both cough
and fast breathing received amoxicillin, although no children received treatment for 5–7 days. Similarly, only 8 (14.3%)
children with diarrhea received oral rehydration salts, but none received zinc tablets. Management of common childhood
illness at private sector drug shops in rural Uganda is largely inappropriate. There is urgent need to improve the standard
of care at drug shops for common childhood illness through public–private partnerships.
INTRODUCTION
Fever-related conditions, including malaria, pneumonia,
and diarrhea, are the major causes of mortality among chil-
dren less than 5 years old in low-income countries.1 In
Uganda, the Home-Based Management of Fever (HBMF)
strategy was initiated in 2002 to treat all febrile children with
antimalarials. The HBMF strategy was promoted through
public and community health worker systems. As a result,
the community health workers’ mandate has been broadened
to use diagnostics such as rapid diagnostic tests (RDTs) for
malaria and respiratory timers for pneumonia and treat
febrile children with antimalarials, antibiotics, and oral rehy-
dration salt with zinc tablets (ORS/Zinc) accordingly. This
new approach is called the integrated community case man-
agement (iCCM) of malaria, pneumonia, and diarrhea in
children, which is now national policy in Uganda.2
Whereas the iCCM strategy is implemented through volun-
teer community health workers, the majority of parents in
Uganda seek care for their febrile children from private
clinics and drug shops.3,4 Unfortunately, the standard of care
in private health facilities, including drug shops, is not well-
documented, although it is known to be wanting. There is
need to study interventions aimed at improving the standard
of care provided by the private sector in the management of
common childhood illnesses.4,5
In 2011, the Global Fund, through the Affordable Medicines
Facility—Malaria (AMFm), began to subsidize and promote
artemisinin combination therapy (ACT) for the treatment of
fever through the private sector in eight low-income countries,
including Uganda.6 Studies have shown that subsidizing ACT
through private drug shops in rural areas can greatly increase
ACT coverage for reported fevers.7,8 Unfortunately, there is
no similar strategy to improve treatment of pneumonia and
diarrhea in the private sector, where many sick children are
first seen.
In addition, studies are exploring the feasibility of introduc-
ing malaria RDT in the private sector. However, there is
extremely limited understanding of how to offer appropriate
alternative treatment to those children with RDT-negative
fever with or without signs of other illnesses.9 This lack of
understanding limits the adherence to RDT results and leads
to continued inappropriate use of ACT, with adverse conse-
quences for cost, resistance development, and children suffer-
ing from other illnesses than malaria.10,11 Furthermore, there
is also indication of increased likely inappropriate use of
antibiotics to treat RDT negative fever.9
The private sector plays an important role for care of febrile
children in Uganda. Through the AMFm, the role of the pri-
vate sector may further be expanded for care of malaria. The
objective of this study was to determine the role and appropri-
ateness of care provided by private sector drug shops in
treating childhood fever, respiratory symptoms, and diarrhea
in Uganda.
METHODS
The study was conducted in two rural districts of Kaliro
and Kamuli in eastern Uganda as part of a baseline assess-
ment for a larger study determining the effectiveness of
introducing and promoting pre-packaged drugs and diagnos-
tics for treatment of childhood fever and diarrhea within
drug shops in Uganda.
The two districts were purposively selected as representa-
tive of a typical rural setting with a high burden of febrile
illness and diarrhea in children. The research strategy
included a community household survey and exit interviews
at drug shops to determine care-seeking patterns and the
appropriateness of treatment provided at drug shops for
febrile children less than 5 years of age in Uganda. All data
were collected in May of 2011.
Household survey. A two-stage cluster sampling using
probability proportional to population size was used to select
1,604 households with children less than 5 years of age in both
study districts. At the first stage, a probability sample of
30 villages/clusters was sampled. At the second stage, 26 tar-
get households were sampled from each cluster. Because of
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the lack of an updated village list of households, it was not
possible to have a random sample within a cluster. The study
team, therefore, randomly identified a starting point from a list
of households obtained from the local leaders and thereafter,
sampled every fifth household with children less than 5 years of
age. The main caretaker (usually the mother) aged 15 years
and above was interviewed face to face using a semistructured
questionnaire. If a sampled house was empty or the caregiver
was absent, it was replaced by the neighboring house. The
questionnaire was designed to elicit care-seeking practice for
the most recent illness (less than 2 weeks before the interview).
Five-day training was conducted for data collectors, and it
included a pilot within a cluster that was not included in the
survey. Five field teams collected the data, and a team was
comprised of four data collectors and one supervisor.
Exit interviews at drug shops. One-half of all the licensed/
registered drug shops in the two study districts were randomly
selected for exit interviews (N = 40). All clients exiting the
drug shops were approached and requested to be interviewed
if they had come to the drug shop seeking treatment of a child
less than 5 years of age. Data collectors were at the drug shop
all day (from 8:30 AM to 7:00 PM) during the study period, and
163 interviews were conducted.
A semistructured questionnaire was used. The questions
asked included what the child’s symptoms were, when the
current illness was noticed, and any care sought before com-
ing to the drug shop. We asked for all the medicines pur-
chased and noted down information, including drug name,
dosage, duration of treatment, and whether instructions were
given on how to use the purchased medicines.
The data were entered separately for the household and
exit interviews in Epi data software, and they were analyzed
using SPSS. Ethical approval was obtained from the Makerere
University School of Public Health Higher Degrees Research
and Ethics Committee as well as the Uganda National Council
of Science and Technology. Informed consent was obtained
from all the study participants.
RESULTS
The median (interquartile range [IQR]) age of the primary
caregiver, number of children less than 5 years old, and house-
hold size were 28 (23, 35) years, 2 (1, 2) children, and 6 (4, 8),
respectively (Table 1). The decision to seek treatment of the ill
child was usually made by the mother in 854 (53.2%) house-
holds, whereas the father/husband mainly authorized expendi-
ture for treatment of sick children in 1,173 (73.1%) households.
Up to 934 (58%) children had been sick within the previous
2 weeks of the study (Table 2). The number of children with
an illness within the last 2 weeks who first sought treatment
in the private sector (private clinics and drug shops) was
496 (53.1%) versus 154 (16.5%) in a government health facil-
ity. Caregivers who first managed the sick child at home were
228 (24.4%), whereas 31 (3.3%) caregivers first visited a com-
munity health worker, 13 (1.4%) caregivers first visited a
traditional healer, and 12 (1.3%) caregivers first visited a
spiritual healer or the church.
The median (IQR) age of children for whom treatment was
sought at the drug shop was 15 (9, 36) months; 65% of the
caretakers who bought drugs for sick children at the drug
shops were female, and their education level was primary in
75 (52.8%) and ordinary level in 53 (37.3%) women. The
main presenting complaint/symptoms for which treatment
was sought at the drug shop was fever in 145 (89%), cough in
100 (61.3%), and diarrhea in 56 (34.4%) children. Both cough
Table 1
Baseline characteristics of the study population (N = 1,604)
Median age (years) of primary
caregiver/respondent (IQR)
28 (23, 35)
Median age (months) of child (IQR) 14 (7, 24)
Median household size (IQR) 6 (4, 8)
Median number of children less than
5 years old in the household (IQR)
2 (1, 2)
Educational background of caretaker/respondent
No education 308 (19.2%)
Primary level 908 (56.6%)
Secondary level 362 (22.6%)
Higher education 26 (1.6%)
Household head
Self (caretaker/respondent) 212 (13.2%)
Partner/husband 1,323 (82.5%)
Other male adult 52 (3.2%)
Other female adult 17 (1.1%)
Educational background of partner/husband
(N = 1,568; some have no partner)
No education 138 (8.8%)
Primary level 809 (51.6%)
Secondary level 422 (26.9)
Higher education 72 (4.6%)
Do not know 127 (8.1%)
Occupation of partner/husband (N = 1,568)
Farmer 896 (57.1%)
Trader 91 (5.8%)
Civil servant 94 (6.0%)
Other office work 54 (3.4%)
Business man/self-used 346 (22.1%)
Unemployed 26 (1.7%)
Do not know 61 (3.9%)
Who makes the decision to seek medical treatment
when a child is sick?
Mother 854 (53.2%)
Husband 312 (19.5%)
Mother and husband together 402 (25.1%)
Relatives/others 36 (2.2%)









Relative (pays no rent) 85 (5.3%)
Other 2 (0.1%)
Table 2
First point where care was sought for illness within the last 2 weeks
in a child less than 5 years of age (N = 934)
Healthcare service provider Number (%)
Private health provider 496 (53.1)
Drug shop 279 (29.9)
Private clinic 217 (23.2)
Managed at home 228 (24.4)
Government health facility 154 (16.5)
Rural health center 120 (12.8)
Hospital 34 (3.6)
Community health worker 31 (3.3)
Traditional healer 13 (1.4)
Spiritual healer/church 12 (1.3)
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and rapid/difficult breathing were the presenting complaint in
32 (19.6%) children (Table 3).
Of all children with fever for whom treatment was sought at
a drug shop, only 15 (10.3%) children received appropriate
treatment according to current national guidelines with an
ACT for 3 days and within 24 hours of onset of illness (Table 4).
For children who presented with cough and fast breathing—
defined as pneumonia according to the iCCM guidelines—
23 (71.9%) children received an antibiotic, although it was
mainly cotrimoxazole (56.3%). Only 5 (15.6%) children were
treated with the recommended first-line drug of amoxicillin.
However, zero children with cough and fast breathing received
amoxicillin for the recommended duration of 5–7 days. Similarly,
only 8 (14.3%) children with diarrhea were treated with ORS,
and none of the children with diarrhea received zinc tablets.
Up to 108 (66.3%) caretakers bought drugs from the drug
shops without a prescription (Table 5). Although the amount
of money available to a care-seeker determined the amount of
drugs bought in 78 (47.8%) cases, the prices of drugs were
reported to be within reach of the majority (113; 69.3%). The
main reasons for seeking care at the drug shop included per-
ceived good service/customer care in 101 (62%) cases, dis-
tance/proximity in 34 (20.9%) cases, good/trained staff in
32 (19.6%) cases, regular supply of drugs in 23 (14.1%) cases,
and the drug seller being a friend in 22 (13.5%) cases (Table 5).
DISCUSSION
In this study, we have documented that the majority of
parents/caretakers in two districts in rural Uganda take their
febrile children to the private sector and that the care that
they receive at drug shops for treatment of the main diseases
causing pediatric death is inadequate. The significant role of
the private sector in healthcare delivery has been previously
described. The work by Rutebemberwa and others3 showed
that 62.7% of care for febrile children sought outside the
home was first obtained from drug shops/private clinics. Our
study confirms this finding, with more than one-half of all care
for children less than 5 years of age being first sought in
private drug shops and clinics. This finding is also in agree-
ment with the finding in the work by Konde-Lule and others4
that private providers play a major role in healthcare delivery
in rural Uganda.
Table 3
Symptoms of the child for whom treatment was sought at the
drug shop
Symptom/complaint (N = 163) Number (%)*
Fever 145 (89)
Cough 100 (61.3)
Rapid/difficult breathing 40 (24.5)




*The total is more than 100%, because more than one complaint is possible.
Table 4
Appropriateness of treatment obtained from drug shops
Appropriateness of treatment of fever,
cough with rapid/fast breathing and diarrhoea Number (%)
Treatment of fever (N = 145)
Proportion of children with fever
receiving any ACT drug
37 (25.5)
Proportion of children with fever
receiving any ACT for 3 days
27 (18.6)
Proportion of children with fever
receiving any ACT within 24 hours
22 (15.2)
Proportion of children with fever
receiving any ACT within 24 hours
of onset of fever and for 3 days
15 (10.3)
Proportion of children with fever
receiving any ACT within 24 hours
of onset of fever and for less than 3 days
1 (0.7)
Proportion of children with fever
receiving any ACT within 24 hours
of onset of fever and for more than 3 days
6 (4.1)
Treatment of cough with rapid/fast
breathing (N = 32)
Proportion of children with both cough
and fast breathing treated with any
antibiotic (amoxicillin, cotrimoxazole,
or any other antibiotic)
23 (71.9)
Proportion of children with both cough and
fast breathing treated with cotrimoxazole only
18 (56.3)
Proportion of children with both cough
and fast breathing treated with amoxicillin
5 (15.6)
Proportion of children with both cough
and fast breathing treated with amoxicillin
for 5–7 days
0
Treatment of diarrhea (N = 56)
Proportion of children with diarrhea
treated with ORS
8 (14.3)
Proportion of children with diarrhea treated
with ORS and zinc
0
Table 5
Accessibility and affordability of drugs from the drug shop (N = 163)
Bought drugs without a prescription 108 (66.3%)
Reason for choosing the drug shop
Good service/customer care 101 (62%)
Distance (proximity) 34 (20.9%)
Good/trained staff 32 (19.6%)
Regular supply of drugs 23 (14.1%)
Drug seller is my friend 22 (13.5%)
How long does it take to walk from
home to this drug shop?
Less than 15 minutes 51 (31.3%)
15–30 minutes 42 (25.8%)
30–60 minutes 39 (23.9%)
1–2 hours 19 (11.7%)
Spent money to get to drug shop? 60 (36.8%)
Median amount spent (range) 1,000 Ugshs (200–7,500)
Walking distance to the nearest
public health facility
Less than 15 minutes 34 (20.9%)
15–30 minutes 39 (23.9%)
30–60 minutes 35 (21.5%)
1–2 hours 28 (17.2%)
Was not able to afford all drugs
prescribed/advised
47 (28.8%)
Why not able to buy all drugs? (N = 47)
I did not have enough money 42 (89.4%)
When buying drugs, what determines
the amount that you buy?
The dosage prescribed 65 (39.9%)
The amount of money that I have 78 (47.8%)
Other 20 (12.3%)
How do you rate prices in the drug
shop with respect to your
ability to buy them?
Too expensive 50 (30.7%)
Prices within my reach 113 (69.3%)
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However, we document that the care received at private
drug shops is poor. According to the current Ugandan iCCM
guidelines for management of fever, cough, and diarrhea, only
10% of febrile children were correctly managed in our study
(that is, correct treatment with ACT for the correct duration
and within 24 hours of onset of illness). Management of cough
with fast breathing at the drug shops was even worse, with no
children receiving the recommended drug—amoxicillin—for
the correct duration of time. Also, no child with diarrhea
received ORS with zinc tablets according to current treatment
guidelines. This more comprehensive assessment of correct
management for a range of symptoms shows similar results to
previous studies of the appropriateness of care provided by the
private sector to sick children less than 5 years of age.5,12,13
Although drug shops in Uganda are commonly owned and
registered by middle-level health workers, they are usually
manned by either lower-level nurses (nursing assistants who
have some level of medical training that allows them to man-
age simple health problems like treatment of fever) or people
with no previous medical training.14 Generally, most drug
shop attendants have some secondary school education.
Given the poor management of childhood malaria, pneumo-
nia, and diarrhea by drug shop attendants and their limited
medical training, there is urgent need for more effective train-
ing and supervision in this part of the private sector.5,14
Although both drug shops and government facilities were
a similar distance from their homes, 62% of the caretakers
interviewed reported that the reason that they chose to seek
care at a drug shop was because of good service/customer care.
Poor interpersonal handling of patients and longer waiting
time at government facilities as well as lack of trust in staff at
public health facilities have been reported as reasons for pre-
ferred use of private drug shops for acute febrile illness.15
Improving customer experience at public health facilities
could, thus, contribute to increased use of these facilities.
The Global Fund now supports the AMFm with subsidized
ACT through the private sector in eight countries. It has
ambitions to increase prompt access to effective antimalarials,
particularly to increase ACT affordability, availability, and
use and crowd out artemisinin monotherapies, chloroquine,
and sulfadoxine-pyrimethamine by gaining market share.
Challenges for the AMFm include ensuring that the subsidy
is passed on to consumers, increasing access to diagnostic
confirmation, reaching the poor and remote, and identifying
appropriate benchmarks to evaluate the AMFm pilots.16
Although increasing prompt access to ACT through the pri-
vate sector through subsidies has been shown to be feasible,7
this access may well come at the expense of rational use when
ACT is used to treat fever presumptively. The experience of
introducing ACT and malaria RDT in the private sector in
Cambodia over the last 10 years has shown challenges in
maintaining constant supply and determining effective incen-
tives for private providers and consumers to use the RDT and
adhere to their results.17 There may also be inadvertent
effects on the use of antibiotics. Studies from Zanzibar18 and
mainland Tanzania9 have shown dramatically increased pre-
scription rates for antibiotics when RDTs were introduced,
particularly in RDT-negative cases.
We hypothesize that adherence to test results, adequate
management of the febrile child, and rational use of ACT as
well as antibiotics may be dependent on diagnostics for
malaria as well as pneumonia (respiratory timers) and alter-
native appropriate treatment being provided, including para-
cetamol, to the likely majority of patients who do not fulfill
the criteria for antimalarial or antibiotic treatment. With
changing epidemiology of malaria and pneumonia, this group
will be a higher and higher proportion of children.19
To realize the full potential of ACT and RDT to treat
malaria and adequately cater to the febrile child, it may, there-
fore, be important to extend the logic and policy recommenda-
tion of integrated community case management of febrile
illness to the private sector. This extension will be in support of
the World Health Organization (WHO)/United Nations Chil-
dren’s Fund (UNICEF) recommendations for managing child-
hood febrile illnesses20 and further explore opportunities to
enhance public–private partnerships. We are now undertaking
a proof-of-concept study of iCCM in registered drug shops in
Uganda and encourage others to do the same in other settings.
Methodological considerations. Part of the data presented
was based on caretaker’s report of child’s illness. This method
is prone to both recall and reporting bias, where a respondent
may not remember relevant details of the illness and may
report what they think is expected of them, respectively. The
use of exit interviews minimized recall bias, because we asked
about a child’s current illness and which drugs were bought at
a drug shop. We also minimized recall bias by considering
only illness that occurred within 2 weeks of the household
interviews, which is a standard and acceptable method applied
in similar cross-sectional surveys. The results obtained are com-
parable with other studies. However, selection bias remains
relevant when exit interviews are used, because people who
seek care from private drug shops may be different from the
general population.
Conclusion. The majority of parents in Uganda first seek
care for febrile children in the private sector, notably drug
shops and private clinics. However, febrile children mostly
receive inappropriate treatment at the private sector drug
shops. This finding means that there is a missed opportunity
for them to access appropriate and timely treatment of
fever, cough, and diarrhea at this level. There is urgent need
to improve the standard of care provided at drug shops
through a mix of appropriate technical solutions (drugs
and diagnostics), training, incentives, regulation, supervision
and information, education, and communication. Public–
private partnerships would provide an adequate avenue for
such improvements.
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